Matches in Nanopublications for { ?s ?p "[Combination of SFN with (-)-epigallocatechin gallate as a demethylating agent is identified as an effective approach for re-expression of estrogen receptor in hormone negative breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 8 of
8
with 100 items per page.
- NP810839.RAAk4P4Keuw9EeFf2tcWkC0v9KDxy2L1tbAOeT8ktrpIQ130_assertion description "[Combination of SFN with (-)-epigallocatechin gallate as a demethylating agent is identified as an effective approach for re-expression of estrogen receptor in hormone negative breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP810839.RAAk4P4Keuw9EeFf2tcWkC0v9KDxy2L1tbAOeT8ktrpIQ130_provenance.
- NP663198.RAm4Sls11Q7g-SK3oYXTpKfKO1iobdcCfHh-lNDyD7hFM130_assertion description "[Combination of SFN with (-)-epigallocatechin gallate as a demethylating agent is identified as an effective approach for re-expression of estrogen receptor in hormone negative breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP663198.RAm4Sls11Q7g-SK3oYXTpKfKO1iobdcCfHh-lNDyD7hFM130_provenance.
- assertion description "[Combination of SFN with (-)-epigallocatechin gallate as a demethylating agent is identified as an effective approach for re-expression of estrogen receptor in hormone negative breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Combination of SFN with (-)-epigallocatechin gallate as a demethylating agent is identified as an effective approach for re-expression of estrogen receptor in hormone negative breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP471819.RAQtrECWvjuKBxsTVxscyNOS6P554sAd-2GZssLwyRCPU130_assertion description "[Combination of SFN with (-)-epigallocatechin gallate as a demethylating agent is identified as an effective approach for re-expression of estrogen receptor in hormone negative breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP471819.RAQtrECWvjuKBxsTVxscyNOS6P554sAd-2GZssLwyRCPU130_provenance.
- NP587385.RAfju5tCp87cOGSlyBPTaNDLzKCsOQLkfDIo91cwz0ujU130_assertion description "[Combination of SFN with (-)-epigallocatechin gallate as a demethylating agent is identified as an effective approach for re-expression of estrogen receptor in hormone negative breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP587385.RAfju5tCp87cOGSlyBPTaNDLzKCsOQLkfDIo91cwz0ujU130_provenance.
- NP1076149.RAh1SPnk7ie7DPbMAs5uLZTm7tq_LAtVcjpU_YJ31V96Y130_assertion description "[Combination of SFN with (-)-epigallocatechin gallate as a demethylating agent is identified as an effective approach for re-expression of estrogen receptor in hormone negative breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1076149.RAh1SPnk7ie7DPbMAs5uLZTm7tq_LAtVcjpU_YJ31V96Y130_provenance.
- NP1076148.RA9946gGzbdGvy60QHm2SXjFSsp3AFbHXE7O2NQtHGbwo130_assertion description "[Combination of SFN with (-)-epigallocatechin gallate as a demethylating agent is identified as an effective approach for re-expression of estrogen receptor in hormone negative breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1076148.RA9946gGzbdGvy60QHm2SXjFSsp3AFbHXE7O2NQtHGbwo130_provenance.